Promising New Treatment for Crohn’s Disease at a Stem Cell Clinic
The increasing prevalence of chronic autoimmune disorders poses significant challenges for modern medicine. Crohn’s Disease is one of the more severe examples. This disease is lifelong and the result of a complex interaction of genetics and environmental factors. Patients are debilitated by constant inflammation in the digestive system. This extreme inflammation can be life disrupting in a multitude of ways. Patients can experience severe abdominal pain, extreme weight loss, chronic exhaustion and anemia. Medicine, in many cases, is ineffective or temporary, leaving a greater need for more progressive treatment options. The length and severity of the disease is exacerbated by the massive and persistent strain it places on the world’s healthcare system. This is a key motivator for the investigation of the field of Regenerative Medicine. Choosing to treat symptoms at a Stem Cell Clinic rather than a traditional medicine and surgical center is a great option. This new paradigm shifts from just temporally controlling disease exacerbations to attempting to restore immune homeostasis.
Crohn’s Disease Mechanism
The impact of Crohn’s Disease on patients is easier to appreciate if we analyze it on the cellular level. The condition is characterized by transmural inflammation which is the inflammation that affects all layers of the intestinal wall. The tissue destruction occurs from a cascade of immune responses that go awry. Some of the specific genetic anomalies that occur are mutations of the NOD2 receptors that lead to a poor response to the commensal gut bacteria. The response of the gut immune system is characterized by an abundance of the macrophage cytokine TNF-α. Additionally, a disequilibrium of the effector and the regulatory T cells occurs and this dysregulation of the immune system response leads to an unending cycle of damage to the mucosa. As a consequence of this, patients develop intestinal fistulas with deep roots and severe Strictures. The continuous ulceration of the mucosa, which absorbs all the nutrients is the reason the affected individuals are malnourished regardless of their food consumption. The mental aspects of this condition are to be made evident by the devastating effects of the gastrointestinal destruction. The patients have a chronic pain and are housing enormous psychological distress due to their condition. The severe symptoms of the condition is the reason why a Stem Cell Clinic must offer a more complete therapy that is not limited to just the suppression of symptoms.
Traditional Treatments
The primary focus of current Crohn’s Disease medicine is to control inflammation via systemic immune suppression. In an effort to quickly control an acute flare-up, doctors will often prescribe corticosteroids. Once an initial flare is under control, the patient is usually shifted to an immunomodulator or one of the newer biologic therapies, which target the specific proteins of the inflammatory cascade. However, there are major shortcomings to these traditional approaches. The long-term use of corticosteroids has an array of significant adverse effects such as osteoporosis and increased risk of other serious infections. Biologics, while initial promising, are associated with the development of anti-drug antibodies which leads to loss of response, and the drug itself. In the event that pharmacology fails, the only course is surgical removal of the inflamed portion of the intestines. This approach is also not curative since the underlying disease persists. The anastomosis (the surgical join) becomes the new “sick” bowel and disease will often recur in a few short years. The inadequacy of current therapies demonstrates the need for Stem Cell Clinic approaches.
Stem Cell Therapy Rationale
A stem cell therapy has the potential to change how mucosal healing occurs within regenerative medicine. A stem cell therapy begins by onboarding the patient to a specialized Stem Cell Clinic, which then allows access to mesenchymal multicellular progenitors. These progenitor cells have powerful immunomodulatory effects, which can benefit Crohn’s Disease. Clinicians most often obtain these cells from umbilical cord blood/wharton’s jelly & placental tissue for optimal regenerative effects. As these progenitor cells have the ability to migrate to actively inflamed tissues, the cells then migrate to the targets within the intestines. As such they repair the injured mucosa with potent immunomodulatory molecules. These include Paracrine molecules such as Prostaglandin E2 (PGE2) and Indoleamine 2,3-Dioxygenase (IDO), which actively antagonize destructive T effector cell responses. Additionally, the stem cells cause local macrophages to adopt an anti-inflammatory tissue repair (M2) macrophage phenotype and remove the pro-inflammatory (M1) macrophage phenotype. Because the stem cells reprogram the macrophages, they can then repair the tissue instead of inducing a generalized immune response and tissue remodeling. Furthermore, these stem cells cause the patient’s resident regulatory T (Treg) cells to hyperactively proliferate and re-establish long-term immune sequestration to the gut microbiome. This protocol is the first to resolve the root cause for the gut immunological dysregulation and promise sustained remission. This is further reinforced by the precise nature of the therapy and the modern regenerative center, which is designed with systemic immunosuppressant precautions built-in.
Upcoming Developments in Thailand
Stem Cell Clinic innovation and opportunity expand with rapid development in the Southeast. Regenerative therapies for Crohn’s Disease offer significant potential, particularly with treatment in Thailand. The country’s healthcare and legal systems support cutting-edge cellular research. Thailand’s specialization in immunology and regenerative medicine attracts international patients. Continued development in laboratory systems enhances the viability of therapeutic cell cultures, further attracting patients. Cell cultures are used in conjunction with strict quality control procedures during all steps of the cell isolation process, through to the administration to the patient. Innovative, complex autoimmune treatments place the country as a global leader. Optimizing global care standards through clinical trials designed for individualized cellular dosing. There are significant improvements anticipated in global care standards as the clinical refinements optimize the dosing and the trials are continuous.